Eugia Pharma Receives USFDA Approval for Dexamethasone SDV 10 mg/1 mL
Published: June 05, 2020
Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexamethasone Sodium Phosphate Injection USP, 10 mg/mL Single-dose Vial.
Refer to package insert for full prescribing information.